123
‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers
(www.theguardian.com)
this post was submitted on 18 Jun 2025
123 points (100.0% liked)
World News
229 readers
683 users here now
Please help and contribute as we vote on rules:
https://quokk.au/post/21590
Other Great Communities:
Rules
Be excellent to each other
founded 8 months ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
Yeah, but then you have packaging costs, and distribution costs, and marketing costs, and shareholder dividends, and CEO bonuses, and AI integration, and lobbying costs....
So really, we're practically losing money at a $450/month subscription.
$450/mo. would be a bargain. They'll be squeezing them for hundreds of thousands a year.